United States Ex Rel. Pogue v. Diabetes Treatment Centers of America, Inc., Hca, Inc. And West Paces Medical Center

444 F.3d 462, 2006 U.S. App. LEXIS 8793, 2006 WL 908768
CourtCourt of Appeals for the Sixth Circuit
DecidedApril 11, 2006
Docket04-6130
StatusPublished
Cited by47 cases

This text of 444 F.3d 462 (United States Ex Rel. Pogue v. Diabetes Treatment Centers of America, Inc., Hca, Inc. And West Paces Medical Center) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Ex Rel. Pogue v. Diabetes Treatment Centers of America, Inc., Hca, Inc. And West Paces Medical Center, 444 F.3d 462, 2006 U.S. App. LEXIS 8793, 2006 WL 908768 (6th Cir. 2006).

Opinions

GIBBONS, J., delivered the opinion of the court, in which CLAY, J., joined.

GRIFFIN, J. (pp. 474 - 478), delivered a separate opinion concurring except as to Section II B.

OPINION

JULIA SMITH GIBBONS, Circuit Judge.

Appellants West Paces Medical Center (“West Paces”) and HCA, Inc. (“HCA”) appeal a discovery order issued by the United States District Court for the District of Columbia in the case of United States ex rel. Pogue v. Diabetes Treatment [465]*465Centers of America, Inc. Plaintiff-appellee Scott Pogue brought suit under the False Claims Act, 31 U.S.C. § 3729 et seq., alleging that various financial incentive arrangements between health care providers and referring physicians violate federal law. Pogue’s case was filed in the United States District Court for the Middle District of Tennessee (the “Tennessee district court”). On October 26, 2000, the Pogue case was transferred by the Judicial Panel on Multi-District Litigation (“JPMDL”), along with related cases from at least ten other districts, for consolidated pretrial proceedings before Judge Royce C. Lam-berth in the United States District Court for the District of Columbia (the “D.C. district court”).

West Paces, a hospital, was one of the original defendants in the Pogue case, but had the claims against it dismissed on May 27, 2004, pursuant to a settlement agreement. The Pogue case continues, however, against Diabetes Treatment Centers of America, Inc. (“DTCA”). HCA, a health care provider with approximately 191 affiliated hospitals worldwide, wholly owns West Paces. Pogue maintains that both West Paces and other HCA-owned hospitals maintained illegal relationships with DTCA. In addition to being the corporate parent of West Paces and the corporate parent of other hospitals allegedly connected to DTCA, HCA is itself a party defendant in many of the other multi-district litigation (“MDL”) cases that have been consolidated before Judge Lamberth along with the Pogue case. The consolidated litigation is collectively captioned In re Columbia/HCA Healthcare Corp. Qui Tam Litigation, No. 10-MS-50 (JPMDL No. 1307). Despite these connections, HCA has never technically been a party to the Pogue ease.

During discovery, HCA inadvertently disclosed certain documents to Pogue. Before Pogue could copy the documents, however, HCA recovered them and asserted that it would not reproduce them because they were privileged attorney-client communications. The district court’s order, which forms the basis of this appeal, compels HCA to turn over to Pogue the previously disclosed documents and further orders that any privilege over the subject matter of the disclosed documents has been waived.

For the following reasons, we dismiss the appeal for lack of jurisdiction.

I.

On February 20, 2002, Pogue served a subpoena duces tecum on HCA, which is headquartered in Nashville, Tennessee. Because Pogue sought to inspect HCA documents in Brentwood, Tennessee, the documents-only subpoena issued from the Tennessee district court.1 After the parties failed to agree on the scope of the production that would occur pursuant to the subpoena, Pogue moved to enforce the subpoena in the D.C. district court. HCA filed a short response to Pogue’s motion, asserting that the D.C. district court lacked jurisdiction to enforce the subpoena duces tecum because only the issuing court may enforce a subpoena. HCA informed Judge Lamberth that it would move the [466]*466Tennessee district court to quash the subpoena.

HCA then filed a motion to quash in the Tennessee district court. In its supporting memorandum, HCA argued that the Tennessee district court was the most appropriate forum to rule upon its motion to quash. Pogue filed a response, opposing the motion, in part, on the grounds the MDL court was the most appropriate forum to enforce, modify, or quash the subpoena. On November 21, 2002, the Tennessee district court issued an order finding that it lacked jurisdiction to consider HCA’s motion to quash. The Tennessee district court held that a motion to quash a subpoena issued in a case that has been transferred for MDL proceedings must be decided by the MDL court, because the motion to quash is part of the consolidated pretrial proceedings. HCA did not appeal the Tennessee district court’s order.

After the Tennessee district court denied HCA’s motion to quash, HCA refiled the motion in the D.C. district court. Pogue then refiled his response to HCA’s motion to quash, as well as the Tennessee district court’s order. Thus, the D.C. district court effectively had before it all of the documents filed with or issued by the Tennessee district court.

In a memorandum opinion and order issued on December 18, 2002, Judge Lam-berth found that he had jurisdiction to rule on Pogue’s motion to compel compliance with the subpoena. United States ex rel. Pogue v. Diabetes Treatment Ctrs. of America, Inc., 238 F.Supp.2d 270, 273 (D.D.C.2002). Finding that HCA’s motion to quash the subpoena was untimely, failed to comply with the local rules of the district in which it was filed, and failed to satisfy the signature requirement of Fed. R.Civ.P. 7(b)(3), Judge Lamberth held that HCA had failed to challenge the merits of Pogue’s motion to compel. Judge Lam-berth issued an order enforcing the subpoena duces tecum as written. Id. at 278-79. In another memorandum opinion also issued on December 18, which concerned the progress of discovery, Judge Lam-berth stated that he trusted that HCA’s response to the discovery orders would take place within the month.

HCA began producing boxes of documents pursuant to the subpoena duces tecum and the D.C. district court’s order enforcing the subpoena on January 6, 2003. Pursuant to prior protective orders issued by the D.C. district court, Pogue’s counsel would review and mark for copying documents of interest, at which point counsel for HCA would screen the marked documents for confidentiality and patient confidentiality. On February 11, 2003, HCA produced 399 additional boxes of documents. During its review of these boxes, Pogue’s counsel identified and marked for copying various documents. Pogue’s counsel also took notes memorializing one such document — a letter from HCA attorney Richard Knight to Joe Calcutt, the Chief Financial Officer of West Paces. The Knight letter discussed a loan from West Paces to a physician. Later that day, during the protective-order review of the documents marked for copying, HCA contract attorneys discovered both the Knight letter, on which Pogue’s counsel had taken notes, as well as one other similar letter. The HCA attorneys removed these documents from the boxes to be copied. The next day, HCA’s counsel sent an email to Pogue’s counsel, indicating that the documents marked for copying had been reviewed “for confidentiality and patient confidentiality” and were ready to be picked up for copying. HCA did not inform Pogue that it had removed any documents from the boxes.

[467]*467Upon additional review of the boxes that were ready for copying, Pogue’s counsel discovered that the Knight letter had been removed. Pogue’s counsel immediately faxed a letter questioning HCA’s counsel about the removal.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kenneth Kelly v. Thomas A. Stewart
Court of Appeals of Tennessee, 2025
Creger v. Tucker
M.D. Tennessee, 2022
Martin v. Turnipseed
Fifth Circuit, 2022
King's Daughters Health Sys.
31 F.4th 520 (Sixth Circuit, 2022)
In re Jack Warren Harang
Sixth Circuit, 2021
Raymond Twyford v. Tim Shoop
11 F.4th 518 (Sixth Circuit, 2021)
Raymond Hall
4 F.4th 376 (Sixth Circuit, 2021)
Lynch v. Ethicon, Inc.
S.D. West Virginia, 2019
Mote v. City of Chelsea
391 F. Supp. 3d 720 (E.D. Michigan, 2019)
Diamond Consortium, Inc. v. Hammervold
386 F. Supp. 3d 904 (M.D. Tennessee, 2019)
Miami-Luken, Inc. v. U.S. Drug Enforcement Admin.
900 F.3d 738 (Sixth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
444 F.3d 462, 2006 U.S. App. LEXIS 8793, 2006 WL 908768, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-pogue-v-diabetes-treatment-centers-of-america-inc-ca6-2006.